Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

Ovarian cancer is not ovarian cancer

By Karen Loudon / October 3, 2023
Cartherics’ Dr Ian Nisbet (Chief Operating Officer) and Kathy Skoff (Clinical Trials Manager) recently attended an ovarian cancer symposium in...
Read More

Combining new and existing immunity: a 3D approach to killing cancer

By Karen Loudon / September 25, 2023
by Richard Boyd and Aleta Pupovac A question which has long baffled scientists, frustrated clinicians and devastated patients is why...
Read More

Heather Hawkins Ovarian Cancer Journey

By Karen Loudon / August 24, 2023
Heather Hawkins, Cartherics Board Advisor and patient advocate, shares her personal journey with ovarian cancer in the hope that it...
Read More